[1]
|
P. H. Plotz, M. Dalakas, R. L. Leff, L. A. Love, F. W. Miller and M. E. Cronin, “Current Concepts in the Idiopathic Inflammatory Myopathies: Polymyositis, Dermatomyositis, and Related Disorders,” Annals of Internal Medicine, Vol. 111, No. 2, 1989, pp. 143-157.
|
[2]
|
T. P. O’Hanlon, D. M. Carrick, I. N. Targoff, F. C. Arnett, J. D. Reveille, M. Carrington, X. Gao, C. V. Oddis, P. A. Morel, J. D. Malley, K. Malley, E. A. Shamim, L. G. Rider, S. J. Chanock, C. B. Foster, T. Bunch, P. J. Blackshear, P. H. Plotz, L. A. Love and F. W. Miller, “Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies,” Medicine (Baltimore), Vol. 85, No. 2, 2006, pp. 111-127.
doi:10.1097/01.md.0000217525.82287.eb
|
[3]
|
M. C. Dalakas and R. Hohlfeld, “Polymyositis and Dermatomyositis,” The Lancet, Vol. 362, No. 9388, 2003, pp. 971-982. doi:10.1016/S0140-6736(03)14368-1
|
[4]
|
M. L. Miller and S. A. Rudnicki, “Treatment of Recurrent and Resistant Dermatomyositis and Polymyositis in Adults.”
http://www.uptodate.com/contents/treatment-of-recurrent-and-resistant-dermatomyositis-and-polymyositis-in-adults?source=search_result&search=dermatomyositis&selectedTitle=8%7E150
|
[5]
|
E. H. Noss, D. L. Hausner-Sypek and M. E. Weinblatt, “Rituximab as Therapy for Refractory Polymyositis and Dermatomyositis,” The Journal of Rheumatology, Vol. 33, No. 5, 2006, pp. 1021-1026.
|
[6]
|
E. A. Mahler, M. Blom, N. C. Voermans, B. G. van Engelen, P. L. van Riel and M. C. Vonk, “Rituximab Treatment in Patients with Refractory Inflammatory Myopathies,” Rheumatology (Oxford), Vol. 50, No. 12, 2011, pp. 2206-2213. doi:10.1093/rheumatology/ker088
|
[7]
|
T. D. Levine, “Rituximab in the Treatment of Dermatomyositis: An Open-Label Pilot Study,” Arthritis & Rheumatism, Vol. 52, No. 2, 2005, pp. 601-607.
doi:10.1002/art.20849
|
[8]
|
A. E. Hak, B. de Paepe, J. L. de Bleecker, P. P. Tak and M. de Visser, “Dermatomyositis and Polymyositis: New Treatment Targets on the Horizon,” Netherlands Journal of Medicine, Vol. 69, No. 10, 2011, pp. 410-421.
|
[9]
|
V. Limaye, P. Hissaria, C. L. Liew and B. Koszyka, “Efficacy of Rituximab in Refractory Antisynthetase Syndrome,” Internal Medicine Journal, Vol. 42, No. 3, 2012, pp. e4-e7.
|
[10]
|
I. Marie and L. Mouthon, “Therapy of Polymyositis and Dermatomyositis,” Autoimmunity Reviews, Vol. 11, No. 1, 2011, pp. 6-13. doi:10.1016/j.autrev.2011.06.007
|